[Response to ABVD chemotherapeutic protocol in patients with early stage Hodgkins lymphoma].
Sign Up to like & getrecommendations! Published in 2017 at "Revista medica de Chile"
DOI: 10.4067/s0034-98872017000500009
Abstract: BACKGROUND Recent trials show that > 90% of patients with early stage Hodgkin`s Lymphoma (ESHL) can be cured, especially when using the ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) chemotherapeutic (CT) protocol. The use of radiotherapy… read more here.
Keywords: patients early; hodgkin lymphoma; stage hodgkin; protocol ... See more keywords